Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	axon guidance receptor activity	EPHB2 EPHB3 HMCN2	6.24e-05	13	123	3	GO:0008046
GeneOntologyMolecularFunction	integrin binding	SELP ITGA2 ITGA2B JAM2 TLN1 TLN2 GPNMB	1.07e-04	175	123	7	GO:0005178
GeneOntologyMolecularFunction	structural constituent of skin epidermis	KRT81 KRT83 KRT85 KRT86	1.40e-04	43	123	4	GO:0030280
GeneOntologyMolecularFunction	ephrin receptor activity	EPHB2 EPHB3 EPHB4	2.06e-04	19	123	3	GO:0005003
GeneOntologyBiologicalProcess	cell-cell adhesion	EPHB3 EPHB4 SELP NPHS1 DCHS2 RAP1GAP PCDHGB2 CDHR2 PDPK1 HLA-DRB1 HLA-DRB5 ITGA2 ITGA2B PDLIM5 JAM2 RHOH FAT1 HMCN2 TLN1 TLN2 GPNMB PCDHGC3	3.69e-07	1077	123	22	GO:0098609
GeneOntologyCellularComponent	anchoring junction	NPHS1 DCHS2 CDHR2 PDPK1 PPP1R12A NCSTN ITGA2 ITGA2B PDLIM5 JAM2 FAT1 LLGL2 LLGL1 TLN1 ARMC5 TLN2 PCDHGC3	5.24e-05	976	122	17	GO:0070161
GeneOntologyCellularComponent	focal adhesion	NPHS1 PDPK1 PPP1R12A NCSTN ITGA2 ITGA2B FAT1 TLN1 ARMC5 TLN2	2.21e-04	431	122	10	GO:0005925
GeneOntologyCellularComponent	cell-substrate junction	NPHS1 PDPK1 PPP1R12A NCSTN ITGA2 ITGA2B FAT1 TLN1 ARMC5 TLN2	2.75e-04	443	122	10	GO:0030055
HumanPheno	Perifollicular hyperkeratosis	KRT81 KRT83 KRT86	3.76e-06	4	51	3	HP:0007468
HumanPheno	Abnormal perifollicular morphology	KRT81 KRT83 KRT86	1.85e-05	6	51	3	HP:0031285
Domain	Keratin_2_head	KRT81 KRT83 KRT85 KRT86	1.66e-05	24	122	4	IPR032444
Domain	Keratin_2_head	KRT81 KRT83 KRT85 KRT86	1.66e-05	24	122	4	PF16208
Domain	Keratin_II	KRT81 KRT83 KRT85 KRT86	2.32e-05	26	122	4	IPR003054
Domain	-	TLN1 TLN2	4.23e-05	2	122	2	1.20.1420.10
Domain	VBS	TLN1 TLN2	4.23e-05	2	122	2	PF08913
Domain	Vinculin-bd_dom	TLN1 TLN2	4.23e-05	2	122	2	IPR015009
Domain	Talin_cent	TLN1 TLN2	4.23e-05	2	122	2	IPR015224
Domain	Talin_middle	TLN1 TLN2	4.23e-05	2	122	2	PF09141
Domain	Ephrin_rec_like	EPHB2 EPHB3 EPHB4	4.32e-05	11	122	3	PF07699
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	5.73e-05	12	122	3	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A5	5.73e-05	12	122	3	IPR027970
Domain	RECEPTOR_TYR_KIN_V_2	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	PS00790
Domain	Tyr_kinase_rcpt_V_CS	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	IPR001426
Domain	EphA2_TM	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	PF14575
Domain	Ephrin_rcpt_lig-bd_dom	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	IPR001090
Domain	Eph_TM	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	IPR027936
Domain	EPH_lbd	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	SM00615
Domain	Ephrin_lbd	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	PF01404
Domain	Tyr_kinase_ephrin_rcpt	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	IPR016257
Domain	EPH_LBD	EPHB2 EPHB3 EPHB4	9.39e-05	14	122	3	PS51550
Domain	Talin-1	TLN1 TLN2	1.26e-04	3	122	2	IPR015710
Domain	LLGL	LLGL2 LLGL1	2.52e-04	4	122	2	PF08366
Domain	ILWEQ_dom	TLN1 TLN2	2.52e-04	4	122	2	IPR002558
Domain	ILWEQ	TLN1 TLN2	2.52e-04	4	122	2	SM00307
Domain	FERM_f0	TLN1 TLN2	2.52e-04	4	122	2	PF16511
Domain	ILWEQ	TLN1 TLN2	2.52e-04	4	122	2	PD011820
Domain	-	TLN1 TLN2	2.52e-04	4	122	2	1.20.1410.10
Domain	I_LWEQ	TLN1 TLN2	2.52e-04	4	122	2	PF01608
Domain	I_LWEQ	TLN1 TLN2	2.52e-04	4	122	2	PS50945
Domain	Lethal2_giant	LLGL2 LLGL1	2.52e-04	4	122	2	IPR000664
Domain	FERM_f0	TLN1 TLN2	2.52e-04	4	122	2	IPR032425
Domain	LLGL2	LLGL2 LLGL1	2.52e-04	4	122	2	IPR013577
Domain	Growth_fac_rcpt_	EPHB2 EPHB3 EPHB4 KRT83 FAT1 HMCN2	5.62e-04	156	122	6	IPR009030
Domain	Ephrin_rec_like	EPHB2 EPHB3 EPHB4	5.63e-04	25	122	3	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB2 EPHB3 EPHB4	5.63e-04	25	122	3	IPR011641
Domain	Cadherin_CS	DCHS2 PCDHGB2 CDHR2 FAT1 PCDHGC3	7.45e-04	109	122	5	IPR020894
Domain	Intermediate_filament_CS	KRT81 KRT83 KRT85 KRT86	7.67e-04	63	122	4	IPR018039
Domain	Vinculin/catenin	TLN1 TLN2	8.70e-04	7	122	2	IPR006077
Domain	CADHERIN_1	DCHS2 PCDHGB2 CDHR2 FAT1 PCDHGC3	8.76e-04	113	122	5	PS00232
Domain	Cadherin	DCHS2 PCDHGB2 CDHR2 FAT1 PCDHGC3	8.76e-04	113	122	5	PF00028
Domain	CADHERIN_2	DCHS2 PCDHGB2 CDHR2 FAT1 PCDHGC3	9.12e-04	114	122	5	PS50268
Domain	-	DCHS2 PCDHGB2 CDHR2 FAT1 PCDHGC3	9.12e-04	114	122	5	2.60.40.60
Domain	CA	DCHS2 PCDHGB2 CDHR2 FAT1 PCDHGC3	9.48e-04	115	122	5	SM00112
Domain	Cadherin-like	DCHS2 PCDHGB2 CDHR2 FAT1 PCDHGC3	9.86e-04	116	122	5	IPR015919
Domain	Cadherin	DCHS2 PCDHGB2 CDHR2 FAT1 PCDHGC3	1.06e-03	118	122	5	IPR002126
Domain	MHC_II_b_N	HLA-DRB1 HLA-DRB5	1.15e-03	8	122	2	PD000328
Domain	Filament	KRT81 KRT83 KRT85 KRT86	1.20e-03	71	122	4	SM01391
Domain	IF	KRT81 KRT83 KRT85 KRT86	1.27e-03	72	122	4	PS00226
Domain	Filament	KRT81 KRT83 KRT85 KRT86	1.33e-03	73	122	4	PF00038
Domain	MHC_II_b_N	HLA-DRB1 HLA-DRB5	1.48e-03	9	122	2	IPR000353
Domain	MHC_II_beta	HLA-DRB1 HLA-DRB5	1.48e-03	9	122	2	SM00921
Domain	MHC_II_beta	HLA-DRB1 HLA-DRB5	1.48e-03	9	122	2	PF00969
Domain	IF	KRT81 KRT83 KRT85 KRT86	1.55e-03	76	122	4	IPR001664
Domain	SAM	EPHB2 EPHB3 EPHB4 TNKS	2.65e-03	88	122	4	SM00454
Domain	SAM_DOMAIN	EPHB2 EPHB3 EPHB4 TNKS	3.49e-03	95	122	4	PS50105
Domain	MHC_II_a/b_N	HLA-DRB1 HLA-DRB5	3.66e-03	14	122	2	IPR014745
Domain	IRS	TLN1 TLN2	3.66e-03	14	122	2	PF02174
Domain	IRS_PTB	TLN1 TLN2	3.66e-03	14	122	2	IPR002404
Domain	-	HLA-DRB1 HLA-DRB5	3.66e-03	14	122	2	3.10.320.10
Domain	SAM	EPHB2 EPHB3 EPHB4 TNKS	3.76e-03	97	122	4	IPR001660
Domain	Ank	TRPV1 CTTNBP2 PPP1R12A RIPK4 LRRK1 TNKS	3.87e-03	228	122	6	PF00023
Domain	fn3	EPHB2 EPHB3 EPHB4 NPHS1 FNDC7	4.24e-03	162	122	5	PF00041
Domain	Integrin_alpha_C_CS	ITGA2 ITGA2B	4.78e-03	16	122	2	IPR018184
Domain	-	EPHB2 EPHB3 EPHB4 TNKS	5.16e-03	106	122	4	1.10.150.50
Domain	Integrin_alpha-2	ITGA2 ITGA2B	6.05e-03	18	122	2	IPR013649
Domain	INTEGRIN_ALPHA	ITGA2 ITGA2B	6.05e-03	18	122	2	PS00242
Domain	Integrin_alpha2	ITGA2 ITGA2B	6.05e-03	18	122	2	PF08441
Domain	Integrin_alpha	ITGA2 ITGA2B	6.05e-03	18	122	2	IPR000413
Domain	ANK	TRPV1 CTTNBP2 PPP1R12A RIPK4 LRRK1 TNKS	6.14e-03	251	122	6	SM00248
Domain	ANK_REPEAT	TRPV1 CTTNBP2 PPP1R12A RIPK4 LRRK1 TNKS	6.38e-03	253	122	6	PS50088
Domain	ANK_REP_REGION	TRPV1 CTTNBP2 PPP1R12A RIPK4 LRRK1 TNKS	6.50e-03	254	122	6	PS50297
Pathway	KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY	ITGA2 ITGA2B TLN1 TLN2	3.13e-05	30	86	4	M47724
Pathway	REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS	EPHB2 EPHB3 EPHB4 NCSTN	5.21e-05	34	86	4	MM15025
Pathway	WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT	EPHB2 EPHB3 EPHB4 STAT3	9.98e-05	40	86	4	M39798
Pathway	WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER	EPHB2 EPHB3 EPHB4 STAT3	1.33e-04	43	86	4	M39788
Pathway	REACTOME_EPHRIN_SIGNALING	EPHB2 EPHB3 EPHB4	1.67e-04	18	86	3	MM15024
Pathway	REACTOME_EPHRIN_SIGNALING	EPHB2 EPHB3 EPHB4	1.98e-04	19	86	3	M27310
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	EPHB2 EPHB3 EPHB4 RAP1GAP KRT81 KRT83 KRT85 KRT86 NCSTN ITGA2B TLN1	2.29e-04	502	86	11	MM14537
Pathway	REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS	EPHB2 EPHB3 EPHB4 NCSTN	2.59e-04	51	86	4	M27311
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	2.37e-09	6	125	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	2.37e-09	6	125	4	25930072
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PPP1R12A SH3BP2 MAZ KAT6A LPCAT4 KIAA1549 SKI PASK TBC1D10B FAT1 RESF1 HMCN2 CHD5 NUP188 TAF4B ADGRL2 VPS51 MGA ALG13	1.95e-08	1116	125	19	31753913
Pubmed	Novel KRT83 and KRT86 mutations associated with monilethrix.	KRT81 KRT83 KRT86	4.53e-08	3	125	3	25557232
Pubmed	Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.	EPHB2 EPHB3 EPHB4	4.53e-08	3	125	3	34296545
Pubmed	Structure and site of expression of a murine type II hair keratin.	KRT81 KRT83 KRT86	4.53e-08	3	125	3	1372089
Pubmed	Transient expression of mouse hair keratins in transfected HeLa cells: interactions between "hard" and "soft" keratins.	KRT81 KRT83 KRT86	4.53e-08	3	125	3	1712823
Pubmed	Sequences and differential expression of three novel human type-II hair keratins.	KRT83 KRT85 KRT86	4.53e-08	3	125	3	9084137
Pubmed	Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain.	KRT81 KRT83 KRT85 KRT86	7.70e-08	12	125	4	10692104
Pubmed	Keratins of the human hair follicle.	KRT81 KRT83 KRT86	1.81e-07	4	125	3	15797458
Pubmed	Talin is required for integrin-mediated platelet function in hemostasis and thrombosis.	ITGA2 ITGA2B TLN1	4.51e-07	5	125	3	18086863
Pubmed	Tracheal separation is driven by NKX2-1-mediated repression of Efnb2 and regulation of endodermal cell sorting.	EPHB2 EPHB3 EPHB4 MUC5B	5.91e-07	19	125	4	35294885
Pubmed	Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.	EPHB2 EPHB3 EPHB4	1.57e-06	7	125	3	9990854
Pubmed	Similarities and Differences in the Way Transmembrane-Type Ligands Interact with the Elk Subclass of Eph Receptors.	EPHB2 EPHB3 EPHB4	1.57e-06	7	125	3	8954633
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31A5 SPATA31A1	1.60e-06	24	125	4	32212159
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	PLEKHG4 PPP1R12A MTMR1 SKI STAT3 SF3B1 AP5Z1 TMF1 ZFR ADGRL2 CABIN1 MGA HSD17B8 TP53BP1	2.68e-06	857	125	14	25609649
Pubmed	Degenerate PCR-based cloning method for Eph receptors and analysis of their expression in the developing murine central nervous system and vasculature.	EPHB2 EPHB3 EPHB4	3.75e-06	9	125	3	11403717
Pubmed	EphrinB1 modulates glutamatergic inputs into POMC-expressing progenitors and controls glucose homeostasis.	EPHB2 EPHB3 EPHB4	3.75e-06	9	125	3	33253166
Pubmed	EphB/syndecan-2 signaling in dendritic spine morphogenesis.	EPHB2 EPHB3 EPHB4	3.75e-06	9	125	3	11580899
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RAP1GAP CTTNBP2 PPP1R12A KIAA1549 MTMR1 ITGA2 PFKM PDLIM5 NWD2 SF3B1 WASHC5 MTERF2 TLN1 KNDC1 TLN2 VPS51 PPP6R2 KNG1	3.78e-06	1431	125	18	37142655
Pubmed	EphB signaling regulates target innervation in the developing and deafferented auditory brainstem.	EPHB2 EPHB3 EPHB4	5.34e-06	10	125	3	22021100
Pubmed	EphB2 guides axons at the midline and is necessary for normal vestibular function.	EPHB2 EPHB3 EPHB4	5.34e-06	10	125	3	10839360
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	HEXA EPHB4 RAP1GAP ZEB1 FYTTD1 PLEKHG4 PPP1R12A SH3BP2 IQCN TBC1D10B TLN1 ARMC5 ALG13 S100PBP	6.41e-06	925	125	14	28986522
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	ZHX3 KRT83 KRT85 PPP1R12A NACA PFKM FBXO30 LLGL1 TLN2 TP53BP1	8.51e-06	472	125	10	38943005
Pubmed	Interaction of H-2Eb with an IAP retrotransposon in the A20/2J B cell lymphoma.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	1353478
Pubmed	Complete cDNA sequences of the HLA-DRB114011, 1402, 1403 and 1404 alleles.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	11972886
Pubmed	Novel HLA-DRB1 alleles discovered during routine sequencing based typing, DRB103052, DRB104032, DRB11139 and DRB11346.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	12028548
Pubmed	ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.	ZEB1 PFKM	1.28e-05	2	125	2	33897890
Pubmed	Complete coding region sequence of E beta k cDNA clones: lack of polymorphism in the NH2-terminus between E beta k and E beta b molecules.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	3150763
Pubmed	Complete cDNA sequence of the HLA-DRB1*09012 allele.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	9777332
Pubmed	Isolation and characterization of a cDNA clone for the murine I-E beta polypeptide chain.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	6324181
Pubmed	The tumor suppressor Lgl1 regulates NMII-A cellular distribution and focal adhesion morphology to optimize cell migration.	LLGL2 LLGL1	1.28e-05	2	125	2	22219375
Pubmed	Mouse MHC class II gene E beta 2 is closely related to E beta and to HLA-DR beta.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	2989167
Pubmed	Hugl1 and Hugl2 in mammary epithelial cells: polarity, proliferation, and differentiation.	LLGL2 LLGL1	1.28e-05	2	125	2	23110097
Pubmed	The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer.	ZEB1 LLGL2	1.28e-05	2	125	2	18199550
Pubmed	RIP4 upregulates CCL20 expression through STAT3 signalling in cultured keratinocytes.	RIPK4 STAT3	1.28e-05	2	125	2	30044012
Pubmed	A missense mutation in the type II hair keratin hHb3 is associated with monilethrix.	KRT83 KRT86	1.28e-05	2	125	2	15744029
Pubmed	HLA-DR2 subtypes form an additional supertypic family of DR beta alleles.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	2885840
Pubmed	Cloning, characterization, and differential expression of MDK2 and MDK5, two novel receptor tyrosine kinases of the eck/eph family.	EPHB3 EPHB4	1.28e-05	2	125	2	7478528
Pubmed	Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.	EPHB2 EPHB4	1.28e-05	2	125	2	22374425
Pubmed	Identification of a new allele, HLA-DRB11366.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	15982265
Pubmed	H2-Eb1 expression is upregulated in the nasal mucosa of allergic rhinitis.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	25543041
Pubmed	Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	1975801
Pubmed	EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.	EPHB2 EPHB4	1.28e-05	2	125	2	16840724
Pubmed	[A 1:2 matched case-control study on the interaction of HPV16E6 and HLA-DR9 allele to esophageal cancer in Kazakh ethnicity, Xinjiang].	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	20193235
Pubmed	ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation.	ITGA2 STAT3	1.28e-05	2	125	2	38142122
Pubmed	Cell-autonomous role of EphB2 and EphB3 receptors in the thymic epithelial cell organization.	EPHB2 EPHB3	1.28e-05	2	125	2	19731361
Pubmed	MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.	ZEB1 STAT3	1.28e-05	2	125	2	27017949
Pubmed	Predicted protein sequence of the murine I-E-beta S-polypeptide chain from cDNA and genomic clones.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	2986145
Pubmed	Platelet collagen receptor alpha2beta1 integrin and glycoprotein IIIa Pl(A1/A2) polymorphisms are not associated with nephropathy in type 2 diabetes.	ITGA2 ITGA2B	1.28e-05	2	125	2	11728949
Pubmed	TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.	TFE3 GPNMB	1.28e-05	2	125	2	31043488
Pubmed	A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	1085338
Pubmed	A variable monilethrix phenotype associated with a novel mutation, Glu402Lys, in the helix termination motif of the type II hair keratin hHb1.	KRT81 KRT86	1.28e-05	2	125	2	9665406
Pubmed	Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.	EPHB2 EPHB3	1.28e-05	2	125	2	22064993
Pubmed	The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.	EPHB2 EPHB4	1.28e-05	2	125	2	19597185
Pubmed	Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	3456344
Pubmed	Molecular basis for the defective expression of the mouse Ew17 beta gene.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	2460545
Pubmed	TRPV1 is crucial for proinflammatory STAT3 signaling and thermoregulation-associated pathways in the brain during inflammation.	TRPV1 STAT3	1.28e-05	2	125	2	27188969
Pubmed	EphB receptors coordinate migration and proliferation in the intestinal stem cell niche.	EPHB2 EPHB3	1.28e-05	2	125	2	16777604
Pubmed	Evidence that MHC I-E dampens thyroid autoantibodies and prevents spreading to a second thyroid autoantigen in I-A(k) NOD mice.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	25811933
Pubmed	A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix.	KRT81 KRT86	1.28e-05	2	125	2	9402962
Pubmed	Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients.	EPHB2 EPHB4	1.28e-05	2	125	2	32286515
Pubmed	A novel HLA-DRB1 allele, DRB1*0707.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	12694577
Pubmed	Limited diversity of HLA-DRB1*02 alleles and DRB1-DRB5 haplotype associations in four United States population groups.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	12694574
Pubmed	circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation.	STAT3 FAT1	1.28e-05	2	125	2	34258151
Pubmed	Peripheral T-cell responses of EphB2- and EphB3-deficient mice in a model of collagen-induced arthritis.	EPHB2 EPHB3	1.28e-05	2	125	2	38558087
Pubmed	H2-EB1 Molecule Alleviates Allergic Rhinitis Symptoms of H2-Eb1 Knockout Mice.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	26714418
Pubmed	Recruitment of multiple alleles within the Eb recombinational hotspot in murine MHC.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	8268654
Pubmed	Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	20064541
Pubmed	Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.	TLN1 TLN2	1.28e-05	2	125	2	26822056
Pubmed	The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.	EPHB2 EPHB4	1.28e-05	2	125	2	25148033
Pubmed	Extracellular rigidity sensing by talin isoform-specific mechanical linkages.	TLN1 TLN2	1.28e-05	2	125	2	26523364
Pubmed	Silencing of a targeted protein in in vivo platelets using a lentiviral vector delivering short hairpin RNA sequence.	ITGA2B TLN1	1.28e-05	2	125	2	17872456
Pubmed	Short-term increases in transient receptor potential vanilloid-1 mediate stress-induced enhancement of neuronal excitation.	TRPV1 GPNMB	1.28e-05	2	125	2	25392504
Pubmed	EphB receptors, mainly EphB3, contribute to the proper development of cortical thymic epithelial cells.	EPHB2 EPHB3	1.28e-05	2	125	2	29027839
Pubmed	Molecular analysis of the hotspot of recombination in the murine major histocompatibility complex.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	3018929
Pubmed	Sequence analysis of MHC class II Eb cDNAs from H2r and H2p haplotypes.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	8662092
Pubmed	Ancient haplotypes of the HLA Class II region.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	16140993
Pubmed	Molecular mapping of murine I region recombinants. III. Crossing over at two discrete sites within the beta 1-beta 2 intron of the E beta gene.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	1918991
Pubmed	Null mutations in EphB receptors decrease sharpness of frequency tuning in primary auditory cortex.	EPHB2 EPHB3	1.28e-05	2	125	2	22022561
Pubmed	Characterization of the molecular defects in the mouse E beta f and E beta q genes. Implications for the origin of MHC polymorphism.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	2106558
Pubmed	Platelet receptor HPA-1 polymorphism of alphaIIbbeta3 and 807 C/T polymorphism of alpha2beta1 and Buerger's disease.	ITGA2 ITGA2B	1.28e-05	2	125	2	17495265
Pubmed	Cell type-specific enhancer element associated with a mouse MHC gene, E beta.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	6087163
Pubmed	Thymus aging in mice deficient in either EphB2 or EphB3, two master regulators of thymic epithelium development.	EPHB2 EPHB3	1.28e-05	2	125	2	32506584
Pubmed	Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	18832704
Pubmed	EphB forward signaling controls directional branch extension and arborization required for dorsal-ventral retinotopic mapping.	EPHB2 EPHB3	1.28e-05	2	125	2	12165470
Pubmed	Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	31882398
Pubmed	Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.	EPHB2 EPHB4	1.28e-05	2	125	2	34360793
Pubmed	Multiple sites of crossing over within the Eb recombinational hotspot in the mouse.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	1347471
Pubmed	The mouse E beta 2 gene: a class II MHC beta gene with limited intraspecies polymorphism and an unusual pattern of transcription.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	3780666
Pubmed	Platelet P-selectin and GPIIb/IIIa expression after liver transplantation and resection.	SELP ITGA2B	1.28e-05	2	125	2	15316595
Pubmed	The Forgotten: Identification and Functional Characterization of MHC Class II Molecules H2-Eb2 and RT1-Db2.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	26740108
Pubmed	Disturbed Expression of EphB4, but Not EphrinB2, Inhibited Bone Regeneration in an In Vivo Inflammatory Microenvironment.	EPHB2 EPHB4	1.28e-05	2	125	2	28077917
Pubmed	The I-J-disparate mouse strains B10.A(3R) and B10.A(5R) have identical E beta sequences.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	2105907
Pubmed	Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.	EPHB2 EPHB4	1.28e-05	2	125	2	36519465
Pubmed	No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	20394989
Pubmed	Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.	EPHB2 EPHB4	1.28e-05	2	125	2	19366806
Pubmed	Comparison of DR beta 1 alleles from diabetic and normal individuals.	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	2884201
Pubmed	A microsatellite-based MHC genotyping system for house mice (Mus domesticus).	HLA-DRB1 HLA-DRB5	1.28e-05	2	125	2	9420473
Pubmed	Myc-Associated Zinc Finger Protein Regulates the Proinflammatory Response in Colitis and Colon Cancer via STAT3 Signaling.	MAZ STAT3	1.28e-05	2	125	2	30181395
Cytoband	15q15-q21	TLN2 TP53BP1	4.40e-05	4	125	2	15q15-q21
Cytoband	12q13	KRT81 KRT83 KRT85 KRT86	4.42e-05	71	125	4	12q13
Cytoband	Ensembl 112 genes in cytogenetic band chr12q13	KRT81 KRT83 KRT85 KRT86 NACA POU6F1 PFKM	1.68e-04	423	125	7	chr12q13
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	2.04e-04	8	125	2	chr9q12
Cytoband	1p36.1-p35	EPHB2 RAP1GAP	2.61e-04	9	125	2	1p36.1-p35
GeneFamily	Keratins, type II	KRT81 KRT83 KRT85 KRT86	6.07e-06	27	81	4	609
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHB2 EPHB3 EPHB4	3.04e-05	14	81	3	1095
GeneFamily	Cadherin related	DCHS2 CDHR2 FAT1	5.63e-05	17	81	3	24
GeneFamily	Membrane associated guanylate kinases\|PDZ domain containing\|Scribble complex	LLGL2 LLGL1	1.18e-04	4	81	2	1224
GeneFamily	Sterile alpha motif domain containing	EPHB2 EPHB3 EPHB4 TNKS	6.55e-04	88	81	4	760
GeneFamily	Fibronectin type III domain containing	EPHB2 EPHB3 EPHB4 NPHS1 FNDC7	7.60e-04	160	81	5	555
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX3 ZEB1	2.00e-03	15	81	2	529
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA2 ITGA2B	2.90e-03	18	81	2	1160
GeneFamily	Ankyrin repeat domain containing	TRPV1 CTTNBP2 PPP1R12A RIPK4 TNKS	4.63e-03	242	81	5	403
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPHB4 SELP BNC2 ZEB1 LPCAT4 JAM2 PLA1A ADGRL2	5.95e-08	187	125	8	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	droplet-Liver-nan-3m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGIF2 PPP1R12A LPCAT4 ITGA2 PFKM ATF6B TNKS	4.18e-07	164	125	7	950f87d9dacee45c9004a9bf894543de38f72ee5
ToppCell	droplet-Liver-nan-3m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGIF2 PPP1R12A LPCAT4 ITGA2 PFKM ATF6B TNKS	4.18e-07	164	125	7	c33910a6d87580902e9e7bd27afe6ea63b5eff8d
ToppCell	droplet-Liver-nan-3m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGIF2 PPP1R12A LPCAT4 ITGA2 PFKM ATF6B TNKS	4.18e-07	164	125	7	bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RGS22 MUC5B RYR3 FAT1 ASXL3 TLN2	9.06e-07	184	125	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RGS22 MUC5B RYR3 FAT1 ASXL3 TLN2	9.06e-07	184	125	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RGS22 MUC5B RYR3 FAT1 ASXL3 TLN2	9.06e-07	184	125	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZEB1 KAT6A SKI STAT3 PASK TAF4B ALG13	1.05e-06	188	125	7	939790f133eac9c12d08db6ddb5f08f5107844e3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB4 SELP ZEB1 HLA-DRB1 RYR3 JAM2 PLA1A	1.12e-06	190	125	7	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_ACKR1+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SELP BNC2 CTTNBP2 ATP10A JAM2 PLA1A ADGRL2	1.43e-06	197	125	7	143607d195c8aa2b94d995af0b2ef38582565611
ToppCell	3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SELP ZEB1 HLA-DRB1 HLA-DRB5 JAM2 PLA1A ADGRL2	1.58e-06	200	125	7	cee07d9370656e1c428a7a9e9fbd175129901374
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	EPHB3 PLEKHG4 TFE3 SLC52A3 HMCN2 MGARP	6.09e-06	160	125	6	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LPCAT4 ATG14 JAM2 SLC52A3 PASK RECQL5	8.33e-06	169	125	6	f086b50791e1c93e253eb5e8d6c4bf617b1416c3
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP TCAF1 ZEB1 ITGA2 JAM2 SLC52A3	8.62e-06	170	125	6	50c6c571591aa4b218caefe5778c570c809f567e
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HEXA SELP SH3BP2 TBC1D10B TLN2 GPNMB	8.62e-06	170	125	6	7534ac69ca3a378df78d61c284e89bc96a71a4a8
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP TCAF1 ZEB1 ITGA2 JAM2 SLC52A3	8.62e-06	170	125	6	8fe32dcf924d5f6665f7febbc9647d96b1e96f06
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP TCAF1 ZEB1 ITGA2 JAM2 SLC52A3	8.62e-06	170	125	6	3232db50b1a40f861e981a1b9c9073b81af9f832
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SELP NCSTN LLGL1 WASHC5 AP5Z1 MVD	9.52e-06	173	125	6	4968712af1cca8c932abd3323631d7dcaffd4a66
ToppCell	Adult-Endothelial-endothelial_cell_of_vein-D231\|Adult / Lineage, Cell type, age group and donor	EPHB4 SELP ZEB1 JAM2 PLA1A ADGRL2	9.84e-06	174	125	6	2dd647c4fdf99fd1f7b838efef01baf2cbc3446d
ToppCell	Adult-Endothelial-endothelial_cell_of_vein\|Adult / Lineage, Cell type, age group and donor	EPHB4 SELP ZEB1 JAM2 PLA1A ADGRL2	1.05e-05	176	125	6	043683c61c5d1a7f8a4666a612310246bd3d83a2
ToppCell	FF-Differ-KC\|World / shred by cell class for mouse tongue	CTTNBP2 KRT81 KRT83 KRT85 KRT86 HHIP	1.16e-05	179	125	6	1526a130565a97c291a25a7a988089bffc1515c1
ToppCell	wk_15-18-Hematologic-Myeloid-APOE+_Mac2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TRPV1 HLA-DRB1 HLA-DRB5 LRRK1 PLA1A GPNMB	1.19e-05	180	125	6	c630a121aedd09a51ea18cc6e8552eb979e5b555
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KRT81 KRT83 KRT86 ZNF831 ATP10A RHOH	1.39e-05	185	125	6	e1fd66f4295056807aa29c0e4ce6b1a79cc8dfcf
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	EPHB2 BNC2 ZEB1 STAT3 FAT1 ALG13	1.57e-05	189	125	6	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP ZEB1 SLC52A3 VSTM4 MANSC1 MTERF2	1.57e-05	189	125	6	ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7
ToppCell	droplet-Tongue-nan-3m-Epithelial-filiform\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 KRT81 KRT83 KRT85 KRT86 HHIP	1.62e-05	190	125	6	251e3a33041023bfc4b547c7eb68cfb8f421636f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB4 SELP ZEB1 HLA-DRB1 RYR3 JAM2	1.72e-05	192	125	6	25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPHB4 SELP ZEB1 JAM2 PLA1A ADGRL2	1.77e-05	193	125	6	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	Endothelial-endothelial_cell_of_vein\|World / Lineage, Cell type, age group and donor	EPHB4 SELP ZEB1 JAM2 PLA1A ADGRL2	1.82e-05	194	125	6	3cbd9622a68e89add90e589867d88c83c5a33476
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB4 SELP ZEB1 HLA-DRB1 HLA-DRB5 JAM2	1.82e-05	194	125	6	fa6d51f36a3dae8763a595c20892987ed454c0f0
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB4 SELP RYR3 JAM2 PLA1A ADGRL2	1.99e-05	197	125	6	87eda06344498dc66cac292cf89746dc90b5cf67
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SELP ZEB1 HLA-DRB1 HLA-DRB5 JAM2 PLA1A	2.04e-05	198	125	6	f7aa809040fa9f5782b92eec1f289d690eb5c7bd
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB4 SELP RYR3 JAM2 PLA1A ADGRL2	2.10e-05	199	125	6	07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8
ToppCell	Endothelial_cells-Endothelial-A\|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id	SELP HLA-DRB1 HLA-DRB5 PDLIM5 JAM2 ADGRL2	2.10e-05	199	125	6	2a1424c61ddcd1fea9574f7a3ad1955387458130
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPHB4 ZEB1 KAT6A JAM2 RESF1 ADGRL2	2.16e-05	200	125	6	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	SELP HLA-DRB1 HLA-DRB5 PDLIM5 JAM2 PLA1A	2.16e-05	200	125	6	2ae62c428728c1d9d4471d4be24bd6ab074fa22c
ToppCell	Parenchyma_COVID-19-Endothelial-TX\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	EPHB4 SELP ZEB1 JAM2 PLA1A ADGRL2	2.16e-05	200	125	6	abcbd5a156aa4fd51d284441388975c81c0b88ae
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPHB4 ZEB1 KAT6A JAM2 RESF1 ADGRL2	2.16e-05	200	125	6	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SELP HLA-DRB1 HLA-DRB5 PDLIM5 STAT3 JAM2	2.16e-05	200	125	6	50b8788494b744e0f0ec8c4d67a1c90ae09dca65
ToppCell	390C-Endothelial_cells-Endothelial-A_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SELP HLA-DRB1 HLA-DRB5 PDLIM5 STAT3 JAM2	2.16e-05	200	125	6	f5f24273bee3259a4a3be99ba53b88defa1286c0
ToppCell	Lung_Parenchyma-Severe-Endothelial\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	EPHB4 SELP ZEB1 JAM2 PLA1A ADGRL2	2.16e-05	200	125	6	d9d0ffa18e5b4647966e19ad9830cbba6120677e
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	EPHB4 SELP ZEB1 JAM2 PLA1A ADGRL2	2.16e-05	200	125	6	e9d5ba140cabae11c437012d519b85f5412dcc94
ToppCell	ASK440-Endothelial-Endothelium\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	SELP HLA-DRB1 HLA-DRB5 JAM2 ADGRL2	2.44e-05	122	125	5	2f76ec3b527e9528fbb006599a96e8bbdf9e0e62
ToppCell	LPS_only-Hematopoietic_Mast-Mast_cells-T-cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF831 RHOH TBC1D10B ACAD8 MGARP	6.55e-05	150	125	5	ccb782fbcb3122266354a112a9a850506664f44d
ToppCell	IIH-CD8-exh_CD4\|IIH / Condition, Cell_class and T cell subcluster	KRT86 PFKM ZNF831 RHOH S100PBP	7.42e-05	154	125	5	a2f51a3c5455fe2483e438375ea856afce8262fe
ToppCell	Adult-Endothelial-endothelial_cell_of_vein-D122\|Adult / Lineage, Cell type, age group and donor	EPHB4 SELP ZEB1 JAM2 PLA1A	8.88e-05	160	125	5	0cfe130606af433b2aa90e0a20b6c44659dd6fd4
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HEXA SELP SH3BP2 TBC1D10B GPNMB	9.42e-05	162	125	5	16d625ac6702f79a83af444d2b3bf6759fd17cf6
ToppCell	Influenza_Severe-cDC\|World / Disease group and Cell class	CTTNBP2 RYR3 IFTAP TLN2 TAF4B	9.98e-05	164	125	5	c984228f73b9aa1aaf948541f64f41ed874770cd
ToppCell	Club-club-16\|World / Class top	PCDHGB2 PDPK1 KRT86 PDLIM5 PASK	1.03e-04	165	125	5	684f3c4872bd630d3f744f15d57dccfd34e96160
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 CTTNBP2 KIAA1549 RYR3 RHOH	1.03e-04	165	125	5	37615622c736e43260c38016e7c9e565ac97a3e8
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 CTTNBP2 KIAA1549 RYR3 RHOH	1.03e-04	165	125	5	640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCell	nucseq-Immune-Hematopoietic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 CTTNBP2 KIAA1549 RYR3 RHOH	1.03e-04	165	125	5	f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGIF2 MAZ RHOH MGARP S100PBP	1.12e-04	168	125	5	1df3c8c7a6dceb901805eaba7f86f9943f4f1a9d
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D122\|Adult / Lineage, Cell type, age group and donor	EPHB4 SELP ZEB1 RYR3 JAM2	1.12e-04	168	125	5	8c3e1e45b422813bcdfa4273b1167db649a312f5
ToppCell	droplet-Lung-nan-3m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGIF2 MAZ RHOH MGARP S100PBP	1.12e-04	168	125	5	1586451d437b70b2dffe41d782b694702dcaf50b
ToppCell	Adult-Endothelial-endothelial_cell_of_vein-D175\|Adult / Lineage, Cell type, age group and donor	SELP ZEB1 JAM2 PLA1A ADGRL2	1.15e-04	169	125	5	e1f0298236e4a1c59077c14f0dd29a78fac12648
ToppCell	NS-critical-d_0-4-Myeloid-Monocyte-derived_DC\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HEXA HLA-DRB1 HLA-DRB5 TLN2 GPNMB	1.15e-04	169	125	5	6fe82db874eff0f86e5c0d1cc81322eb9d7874eb
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	BNC2 CTTNBP2 KIAA1549 RYR3 RHOH	1.15e-04	169	125	5	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	COVID-19-lung-MAST\|lung / Disease (COVID-19 only), tissue and cell type	BNC2 CTTNBP2 KIAA1549 RYR3 RHOH	1.18e-04	170	125	5	e90f18e5462381b38e918442b38b1c8105291908
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	BNC2 CTTNBP2 KIAA1549 RYR3 RHOH	1.18e-04	170	125	5	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF831 ATP10A RHOH TBC1D10B TAF4B	1.21e-04	171	125	5	539ea88acc6f948efdeae8b69e5c5ffaee29f1d9
ToppCell	LPS-IL1RA-Lymphocytic_NKT-T_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF831 ATP10A RHOH TBC1D10B TAF4B	1.25e-04	172	125	5	0fc692be845d4225ff8b63bf9195724fc8510c2c
ToppCell	Immune-mast_cell\|World / Lineage, Cell type, age group and donor	SELP KIAA1549 ITGA2B RYR3 RHOH	1.25e-04	172	125	5	6e8e0aac5a20dbc789bf8c6916833bb8709a411a
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	OSTM1 ITGA2B TRAPPC8 RECQL5 PPP6R2	1.25e-04	172	125	5	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	T_cells-CD56_bright_CD16-_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PLEKHG4 KRT81 KRT86 KIAA1549 RYR3	1.25e-04	172	125	5	980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4
ToppCell	Healthy/Control-MAIT\|Healthy/Control / Disease group and Cell class	RAP1GAP PRSS38 LPCAT4 ZNF831 RHOH	1.28e-04	173	125	5	56247c1e07477a8922fe2e3950ae05e2217fd77c
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SELP ZEB1 HLA-DRB5 JAM2 PLA1A	1.28e-04	173	125	5	b57d14e2c2368304cb903562d06ce8228f53857c
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZHX3 PLEKHG4 ATG2B FHIP2A GPNMB	1.32e-04	174	125	5	a1f745962a104c6f4b86b7e482da8755384c773a
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS22 RYR3 RHOH TLN2 MGARP	1.32e-04	174	125	5	f230d23618a6487f2664efb2c677e0a4559e2bf4
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF831 CHRM4 RHOH RESF1 MGARP	1.32e-04	174	125	5	33386750842c47ad7e7286d0f26a556da1a2de02
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SELP VSTM4 HHIP FAT1 CHD5	1.32e-04	174	125	5	a7ade7372e83edd4e3983e77f8417b51f0b47340
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SELP ATP10A HHIP CHD5 GPNMB	1.32e-04	174	125	5	eb8012823b08729b462d1e5212f4873bb6b4eb1e
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF831 CHRM4 RHOH RESF1 MGARP	1.32e-04	174	125	5	9344d4e76d7d9429aea87d3c0b98246200d16014
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SELP ATP10A HHIP CHD5 GPNMB	1.32e-04	174	125	5	32fdeeebeeeca657eac6329caad4c28ca54e4d1c
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NPHS1 CTTNBP2 ATP10A RYR3 FAT1	1.35e-04	175	125	5	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ZHX3 PLEKHG4 ATG2B FHIP2A GPNMB	1.35e-04	175	125	5	78a86cac3e6c0d115c997d1c29ee0e24af54551f
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF831 ATP10A RHOH TBC1D10B TAF4B	1.39e-04	176	125	5	9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575
ToppCell	Int-URO-Lymphocyte-T_NK-gdT\|Int-URO / Disease, Lineage and Cell Type	POU6F1 SLC52A3 RHOH LLGL2 PCDHGC3	1.39e-04	176	125	5	15016a73c953d8d3e7c32a05ead5e7261f9914ca
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF831 ATP10A RHOH TBC1D10B TAF4B	1.39e-04	176	125	5	bb41e9478373726eb460af764de0277b2d09928e
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SELP JAM2 SLC52A3 MANSC1 HMCN2	1.39e-04	176	125	5	52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF831 ATP10A RHOH TBC1D10B TAF4B	1.39e-04	176	125	5	ea27e18407b8a13e8212830da859efeb8f158690
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF831 ATP10A RHOH TBC1D10B TAF4B	1.39e-04	176	125	5	bfbab3c5b738b3b0b1540f2059d0245fbd8c0031
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA2 LLGL2 KNDC1 ADGRL2 KNG1	1.43e-04	177	125	5	c9e8149639551a4c8daa90fcb2b895fdcff2e2ba
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HEXA HLA-DRB1 HLA-DRB5 ATP10A GPNMB	1.46e-04	178	125	5	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 SELP JAM2 SLC52A3 ADGRL2	1.46e-04	178	125	5	ebfae386a518ea33911ba3ff40464c94d18ef695
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 SELP JAM2 SLC52A3 ADGRL2	1.46e-04	178	125	5	ccd37575b60102f5e647c01546e8ff8fec638bd7
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 SELP JAM2 SLC52A3 ADGRL2	1.46e-04	178	125	5	87b04753650e45f12299c8456fb980d6c0d5961c
ToppCell	368C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EPHB2 PDPK1 KRT86 ACAD8 ARMC5	1.54e-04	180	125	5	eb5a57604c7f2ad256c300085dbf5069d0ae1ad0
ToppCell	368C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EPHB2 PDPK1 KRT86 ACAD8 ARMC5	1.54e-04	180	125	5	ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c
ToppCell	Endothelial-A-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	SELP ZEB1 JAM2 PLA1A ADGRL2	1.54e-04	180	125	5	4c3376169770ee9f9283daae44c17f35e46bfd19
ToppCell	severe-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	KRT81 ITGA2B PDLIM5 VSTM4 RHOH	1.54e-04	180	125	5	ac03812b1409435c55d323a7516deeac82bd3509
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HLA-DRB1 HLA-DRB5 ITGA2B FAT1 HMCN2	1.62e-04	182	125	5	1d37c486173cc4629842893ddd5033987c04086f
ToppCell	T_cells-Resident_memory_CD8+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	EPHB3 CTTNBP2 KRT81 KRT86 ITGA2	1.62e-04	182	125	5	111d434b89902ec11fb07f41b8ee1a98f3991b61
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HLA-DRB1 HLA-DRB5 ITGA2B FAT1 HMCN2	1.62e-04	182	125	5	aef67bdc6937b315522d39959e26c9b0acf7ab52
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-DC\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HLA-DRB1 HLA-DRB5 ITGA2B FAT1 HMCN2	1.62e-04	182	125	5	087c9f88daf08f5d688b728c2386f91f210d2255
ToppCell	wk_08-11-Hematologic_Lymphocytic-T_&_ILC-ILCP\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KRT81 KRT83 KRT86 ZNF831 RHOH	1.67e-04	183	125	5	797eb968c57e48db33ff8e2236ee22e9425c4676
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KRT81 KRT86 ZNF831 ATP10A RHOH	1.71e-04	184	125	5	3e9d75af578297950e469f23fb2d28393a2feef8
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SELP ZEB1 JAM2 HMCN2 PLA1A	1.71e-04	184	125	5	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EPHB2 BNC2 ZEB1 RYR3 VSTM4	1.75e-04	185	125	5	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	Endothelial-A-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	SELP ZEB1 RYR3 JAM2 PLA1A	1.75e-04	185	125	5	ae49c61f6ecf128fe2a958b8c75c83688da75f59
Drug	Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A	RAP1GAP SH3BP2 LRRK1 PASK AP5Z1 RECQL5 PPP6R2 CWF19L1 MVD	1.11e-06	197	121	9	5800_DN
Drug	2-acetylfuran	HEXA ITGA2 VPS51	1.45e-06	5	121	3	CID000014505
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A	EPHB4 MTMR1 SKI MANSC1 RECQL5 TMF1 CABIN1 MGA	8.17e-06	190	121	8	7070_UP
Drug	Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; HL60; HT_HG-U133A	EPHB2 SLCO3A1 POU6F1 PASK RHOH RECQL5 NUP188 CWF19L1	9.51e-06	194	121	8	2735_DN
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	EPHB3 LPCAT4 ITGA2B TLN1 TLN2 CABIN1 PPP6R2 ALG13	9.88e-06	195	121	8	2087_UP
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	SH3BP2 LPCAT4 RIPK4 PASK AP5Z1 TLN1 RECQL5 PPP6R2	1.03e-05	196	121	8	5341_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	EPHB2 ZEB1 SH3BP2 MAZ MTMR1 PDLIM5 PASK PLA1A	1.06e-05	197	121	8	4461_DN
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; HL60; HT_HG-U133A	EPHB4 BNC2 ZEB1 ITGA2 PASK TLN1 RECQL5 CABIN1	1.10e-05	198	121	8	2139_DN
Drug	haloperidol; Up 200; 10uM; HL60; HT_HG-U133A	EPHB3 ZHX3 SH3BP2 SLCO3A1 ATP10A TLN2 TNKS NUP188	1.10e-05	198	121	8	6163_UP
Drug	MW 1	KRT81 KRT83 KRT86 SKI STAT3 RYR3 KNG1	1.65e-05	151	121	7	CID000073965
Drug	Hlamp	SELP ITGA2B PDLIM5	2.34e-05	11	121	3	CID000195011
Drug	melicopicine	KRT81 KRT83	2.80e-05	2	121	2	CID000101253
Drug	SR 121566	SELP ITGA2B	2.80e-05	2	121	2	ctd:C106774
Drug	tebuquine	KRT81 KRT83	2.80e-05	2	121	2	CID000071991
Drug	3,5-di-O-galloylquinic acid	KRT81 KRT83	2.80e-05	2	121	2	CID000460896
Drug	U121	MGAM ITGA2	2.80e-05	2	121	2	CID004438528
Drug	arteether	KRT81 KRT83 PLA1A	4.03e-05	13	121	3	CID000072416
Drug	Hb 7	KRT81 KRT83 KRT85	5.11e-05	14	121	3	CID000128180
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	EPHB2 TGIF2 KAT6A SKI PDLIM5 SF3B1 ZFR	7.39e-05	191	121	7	4279_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	MAZ MTMR1 PASK TLN1 TAF4B CABIN1 PPP6R2	7.63e-05	192	121	7	4330_DN
Drug	Delcorine; Up 200; 8.4uM; PC3; HT_HG-U133A	HEXA ZHX3 CDHR2 KAT6A LRRK1 JAM2 TNKS	7.63e-05	192	121	7	3715_UP
Drug	rosiglitazone maleate; Down 200; 10uM; PC3; HG-U133A	CHRM4 LLGL1 TLN2 PPP6R2 CWF19L1 KNG1 S100PBP	8.15e-05	194	121	7	430_DN
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A	EPHB2 MAZ MTMR1 ITGA2B PASK TLN1 TLN2	8.15e-05	194	121	7	4301_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	EPHB2 EPHB3 SH3BP2 MAZ TLN1 RECQL5 CABIN1	8.15e-05	194	121	7	4325_DN
Drug	sulfonamide-3	KRT81 KRT83	8.37e-05	3	121	2	CID009847197
Drug	6-Odbcn	MGAM ITGA2	8.37e-05	3	121	2	CID000131989
Drug	Li2CuCl4	MGAM ITGA2	8.37e-05	3	121	2	CID000193501
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	EPHB2 EPHB4 SH3BP2 KAT6A SKI AP5Z1 RECQL5	8.41e-05	195	121	7	4298_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A	ZHX3 DCHS2 CDHR2 POU6F1 ATP10A RECQL5 ADGRL2	8.41e-05	195	121	7	2394_UP
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ZHX3 SH3BP2 LPCAT4 RECQL5 TLN2 TAF4B CWF19L1	8.69e-05	196	121	7	3329_DN
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	DCHS2 KRT83 SH3BP2 KAT6A SLCO3A1 MUC5B TP53BP1	8.69e-05	196	121	7	3253_UP
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ZEB1 KRT83 KAT6A SKI AP5Z1 RECQL5 NUP188	8.69e-05	196	121	7	4347_DN
Drug	Retrorsine [480-54-6]; Down 200; 11.4uM; PC3; HT_HG-U133A	EPHB2 EPHB3 MAZ LRRK1 ITGA2B AP5Z1 CWF19L1	8.69e-05	196	121	7	6601_DN
Drug	Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	EPHB2 ZEB1 CDHR2 KRT83 SH3BP2 KAT6A CHD5	8.69e-05	196	121	7	6084_UP
Drug	Etomidate [33125-97-2]; Up 200; 16.4uM; HL60; HT_HG-U133A	RAP1GAP SLCO3A1 POU6F1 ATP10A PDLIM5 AP5Z1 TLN2	8.69e-05	196	121	7	2958_UP
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	EPHB3 SH3BP2 MTMR1 PDLIM5 PLA1A GPNMB CWF19L1	9.26e-05	198	121	7	4448_DN
Drug	Trichlormethiazide [133-67-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A	EPHB2 EPHB3 KRT83 POU6F1 NUP188 CABIN1 MVD	9.26e-05	198	121	7	3337_UP
Drug	Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	EPHB2 SH3BP2 MAZ LPCAT4 SKI PDLIM5 MANSC1	9.26e-05	198	121	7	4142_UP
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	EPHB2 ZEB1 SLCO3A1 ITGA2 AP5Z1 RECQL5 NUP188	9.26e-05	198	121	7	3831_UP
Drug	Zidovudine, AZT [30516-87-1]; Up 200; 15uM; HL60; HG-U133A	EPHB4 NCSTN ITGA2B ATP10A CHRM4 TBC1D10B AP5Z1	9.26e-05	198	121	7	1595_UP
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	EPHB4 ZHX3 ZEB1 CDHR2 RIPK4 ITGA2 RECQL5	9.26e-05	198	121	7	5684_DN
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	EPHB2 EPHB4 TRPV1 PDPK1 MANSC1 ZFR PPP6R2	9.55e-05	199	121	7	1815_DN
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A	ATG2B LPCAT4 RHOH AP5Z1 RECQL5 NUP188 CWF19L1	9.55e-05	199	121	7	2858_DN
Drug	(+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA	EPHB3 ZHX3 LPCAT4 RIPK4 PASK PPP6R2 MVD	9.55e-05	199	121	7	954_DN
Drug	Phenindione [83-12-5]; Down 200; 18uM; HL60; HG-U133A	SELP TGIF2 PDPK1 LRRK1 RHOH AP5Z1 ZFR	9.55e-05	199	121	7	1718_DN
Drug	ATBI	KRT81 KRT83 KRT86	1.13e-04	18	121	3	CID000505862
Drug	St. Thomas' Hospital cardioplegic solution	SELP ZEB1 CTTNBP2 PFKM PDLIM5 ADGRL2	1.13e-04	142	121	6	ctd:C041711
Drug	CD 86022	HEXA MGAM ADGRL2	1.33e-04	19	121	3	CID000122617
Drug	AC1L9KQO	HEXA KRT81 KRT83 RYR3	1.34e-04	49	121	4	CID000447335
Drug	Adenosine Diphosphate	SELP ITGA2 ITGA2B PFKM	1.56e-04	51	121	4	ctd:D000244
Drug	DBNPA	MGAM ITGA2	1.67e-04	4	121	2	CID000025059
Drug	Lactupicrin	KRT81 KRT83	1.67e-04	4	121	2	CID000174880
Drug	isomaltol	SELP ITGA2B	1.67e-04	4	121	2	CID000018898
Drug	2-acetylthiophene	HEXA ITGA2	1.67e-04	4	121	2	CID000006920
Drug	LaI3	MGAM ITGA2	1.67e-04	4	121	2	CID000083743
Drug	lactucin	KRT81 KRT83	1.67e-04	4	121	2	CID000442266
Drug	N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate	SELP ITGA2B	1.67e-04	4	121	2	ctd:C111914
Disease	MONILETHRIX	KRT81 KRT83 KRT86	6.40e-08	3	119	3	158000
Disease	Beaded hair	KRT81 KRT83 KRT86	6.40e-08	3	119	3	cv:C0546966
Disease	monilethrix (is_implicated_in)	KRT81 KRT83 KRT86	6.40e-08	3	119	3	DOID:0050472 (is_implicated_in)
Disease	Monilethrix	KRT81 KRT83 KRT86	2.55e-07	4	119	3	C0546966
Disease	Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in)	HLA-DRB1 HLA-DRB5	1.61e-05	2	119	2	DOID:11266 (is_implicated_in)
Disease	hair disease (is_implicated_in)	KRT81 KRT86	1.61e-05	2	119	2	DOID:421 (is_implicated_in)
Disease	T-Cell Lymphoma	STAT3 ASXL3 MGA	3.45e-05	16	119	3	C0079772
Disease	acute disseminated encephalomyelitis (is_implicated_in)	HLA-DRB1 HLA-DRB5	4.83e-05	3	119	2	DOID:639 (is_implicated_in)
Disease	Glanzmann's thrombasthenia (is_implicated_in)	ITGA2 ITGA2B	4.83e-05	3	119	2	DOID:2219 (is_implicated_in)
Disease	ubiquitin carboxyl-terminal hydrolase 25 measurement	HLA-DRB1 HLA-DRB5 ATF6B	9.31e-05	22	119	3	EFO_0021881
Disease	von Willebrand's disease 1 (is_implicated_in)	ITGA2 ITGA2B	9.63e-05	4	119	2	DOID:0060573 (is_implicated_in)
Disease	Coughing	TRPV1 KNG1	9.63e-05	4	119	2	C0010200
Disease	Allergic Reaction	SELP HLA-DRB1 HLA-DRB5 KNG1	1.25e-04	63	119	4	C1527304
Disease	Hypersensitivity	SELP HLA-DRB1 HLA-DRB5 KNG1	1.33e-04	64	119	4	C0020517
Disease	neuroblastoma (implicated_via_orthology)	LLGL2 LLGL1	1.60e-04	5	119	2	DOID:769 (implicated_via_orthology)
Disease	hepatocyte nuclear factor 4-alpha measurement	HLA-DRB1 HLA-DRB5	1.60e-04	5	119	2	EFO_0801672
Disease	nephrotic syndrome	NPHS1 HLA-DRB1 HLA-DRB5 NWD2	1.98e-04	71	119	4	EFO_0004255
Disease	Neonatal Alloimmune Thrombocytopenia	ITGA2 ITGA2B	2.39e-04	6	119	2	C3853779
Disease	FNAITP	ITGA2 ITGA2B	2.39e-04	6	119	2	C3854603
Disease	Behcet's disease (is_implicated_in)	HLA-DRB1 ITGA2 STAT3	4.14e-04	36	119	3	DOID:13241 (is_implicated_in)
Disease	interleukin-21 measurement	HLA-DRB1 HLA-DRB5	4.44e-04	8	119	2	EFO_0801724
Disease	tyrosine-protein kinase receptor TYRO3 measurement	MGAM MGA	4.44e-04	8	119	2	EFO_0020829
Disease	Epstein Barr virus nuclear antigen 1 IgG measurement	HLA-DRB1 HLA-DRB5	5.70e-04	9	119	2	EFO_0007790
Disease	idiopathic pulmonary fibrosis (is_implicated_in)	HLA-DRB1 MUC5B	5.70e-04	9	119	2	DOID:0050156 (is_implicated_in)
Disease	central nervous system non-hodgkin lymphoma	HLA-DRB1 HLA-DRB5	5.70e-04	9	119	2	MONDO_0044887
Disease	HLA class II histocompatibility antigen, DQ alpha 2 chain measurement	HLA-DRB1 HLA-DRB5	5.70e-04	9	119	2	EFO_0801686
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	ZHX3 HLA-DRB1 STAT3 TNKS TP53BP1	5.78e-04	166	119	5	EFO_0004530, EFO_0004611
Disease	CCL19 measurement	HLA-DRB1 HLA-DRB5	7.11e-04	10	119	2	EFO_0009415
Disease	Myocardial Ischemia	SELP ZEB1 CTTNBP2 PFKM PDLIM5	7.53e-04	176	119	5	C0151744
Disease	Bell's palsy	MGAM CDK5RAP3 TAF4B MGA	7.88e-04	102	119	4	EFO_0007167
Disease	insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation	TLN2 ADGRL2	8.66e-04	11	119	2	EFO_0004471, EFO_0009131
Disease	kidney cancer (implicated_via_orthology)	LLGL2 LLGL1	8.66e-04	11	119	2	DOID:263 (implicated_via_orthology)
Disease	anti-Epstein Barr virus antibody measurement	HLA-DRB1 HLA-DRB5	1.04e-03	12	119	2	EFO_0009273
Disease	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	STAT3 MGA	1.04e-03	12	119	2	C0023485
Disease	triglyceride measurement, intermediate density lipoprotein measurement	HLA-DRB1 STAT3 PPP6R2 TP53BP1	1.08e-03	111	119	4	EFO_0004530, EFO_0008595
Disease	complement C4 measurement	HLA-DRB1 HLA-DRB5 ATF6B	1.22e-03	52	119	3	EFO_0004984
Disease	Mammary Carcinoma, Human	EPHB4 ZEB1 PDPK1 STAT3 LLGL2 LLGL1 GPNMB TP53BP1	1.33e-03	525	119	8	C4704874
Disease	Mammary Neoplasms, Human	EPHB4 ZEB1 PDPK1 STAT3 LLGL2 LLGL1 GPNMB TP53BP1	1.33e-03	525	119	8	C1257931
Disease	Malignant neoplasm of breast	EPHB4 RAP1GAP ZEB1 PDPK1 TRAPPC8 STAT3 LLGL2 LLGL1 CHD5 GPNMB HSD17B8 TP53BP1	1.35e-03	1074	119	12	C0006142
Disease	Mammary Neoplasms	EPHB4 ZEB1 PDPK1 STAT3 LLGL2 LLGL1 GPNMB TP53BP1	1.36e-03	527	119	8	C1458155
Disease	C-C motif chemokine 19 measurement	HLA-DRB1 HLA-DRB5	1.42e-03	14	119	2	EFO_0008047
Disease	Breast Carcinoma	EPHB4 ZEB1 PDPK1 STAT3 LLGL2 LLGL1 GPNMB TP53BP1	1.55e-03	538	119	8	C0678222
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	ZHX3 HLA-DRB1 TNKS PPP6R2 TP53BP1	1.83e-03	215	119	5	EFO_0008317, EFO_0008591
Disease	idiopathic dilated cardiomyopathy	MGAM TCAF1 IFTAP	1.85e-03	60	119	3	EFO_0009094
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	ZHX3 HLA-DRB1 TNKS PPP6R2 TP53BP1	2.02e-03	220	119	5	EFO_0004529, EFO_0008317
Disease	anti-anoctamin 2 antibody measurement	HLA-DRB1 HLA-DRB5	2.11e-03	17	119	2	EFO_0010150
Disease	response to interferon-beta, anti-drug antibody measurement	HLA-DRB1 HLA-DRB5	2.11e-03	17	119	2	EFO_0010559, GO_0035456
Disease	ovarian neoplasm	BNC2 ZEB1 STAT3 TP53BP1	2.16e-03	134	119	4	C0919267
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	HLA-DRB1 STAT3 LLGL2 TNKS TP53BP1	2.18e-03	224	119	5	EFO_0004530, EFO_0008317
Disease	Juvenile-Onset Still Disease	HLA-DRB1 ITGA2B STAT3 MEX3C	2.22e-03	135	119	4	C0087031
Disease	Malignant neoplasm of ovary	BNC2 ZEB1 STAT3 TP53BP1	2.34e-03	137	119	4	C1140680
Disease	late-onset myasthenia gravis	HLA-DRB1 HLA-DRB5	2.37e-03	18	119	2	EFO_1001490
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	ZHX3 HLA-DRB1 TNKS PPP6R2 TP53BP1	2.40e-03	229	119	5	EFO_0004639, EFO_0008317
Disease	histidine measurement	PFKM KNG1 TP53BP1	2.43e-03	66	119	3	EFO_0009769
Disease	Usual Interstitial Pneumonia	MUC5B STAT3	2.64e-03	19	119	2	C4721509
Disease	Hamman-Rich Disease	MUC5B STAT3	2.64e-03	19	119	2	C4721508
Disease	renal cell carcinoma (is_implicated_in)	HLA-DRB1 STAT3 TFE3	2.76e-03	69	119	3	DOID:4450 (is_implicated_in)
Disease	atherosclerosis (biomarker_via_orthology)	SELP STAT3	2.92e-03	20	119	2	DOID:1936 (biomarker_via_orthology)
Disease	Familial Idiopathic Pulmonary Fibrosis	MUC5B STAT3	2.92e-03	20	119	2	C4721952
Disease	myocardial infarction	ZHX3 CTTNBP2 SKI ZNF831 PDLIM5 STAT3	3.01e-03	350	119	6	EFO_0000612
Disease	TNF-related apoptosis-inducing ligand measurement	TRAPPC8 ASXL3 KNG1	3.11e-03	72	119	3	EFO_0008300
Disease	Idiopathic Pulmonary Fibrosis	MUC5B STAT3	3.22e-03	21	119	2	C1800706
Disease	Henoch-Schoenlein purpura	HLA-DRB1 HLA-DRB5	3.53e-03	22	119	2	EFO_1000965
Disease	progression free survival, ovarian serous carcinoma	MGAM MGA	3.53e-03	22	119	2	EFO_0004920, EFO_1001516

Protein segments in the cluster

Peptide	Gene	Start	Entry
NECVTAIEIVPATPA	CHRM4	351	P08173
VAASCANNVPAPVLS	ALG13	851	Q9NP73
AAVAAAVETVTISPP	CHD5	211	Q8TDI0
QPTRAVIFEDCAVPV	ACAD8	241	Q9UKU7
PRFCDIPSQSVEVSQ	ATG14	441	Q6ZNE5
CVSPIQNSAPVSDLT	BNC2	401	Q6ZN30
PTCEITQNTVCSPVD	GPNMB	431	Q14956
VPLPNSVFVNTTESC	SH3BP2	451	P78314
TQCIVVTGSDVFPDP	ADGRL2	101	O95490
LAETVVCNAPSAPVF	ADGRL2	1191	O95490
SCLQDLVSPTVSPAV	ARMC5	706	Q96C12
PSVAQFVLTPSTEVC	AP5Z1	761	O43299
PANCRISVQVATPAL	ATG2B	736	Q96BY7
RTEASVQPVACPQVS	ASXL3	1506	Q9C0F0
TICNTVVVTSPDQPR	ATP10A	576	O60312
TEILPTCNPSTVLTA	NWD2	971	Q9ULI1
APITTVVTTGCEPQC	MUC5B	3561	Q9HC84
PESQATITRCSQPLV	MTMR1	296	Q13613
QTVTIRFPCPVSLDA	IQCN	241	Q9H0B3
IQSTFSINPEIVCDP	NCSTN	236	Q92542
CAACTVPSPQQVLAT	KIAA1549	421	Q9HCM3
VLVQCLPPAAVTAVT	LLGL1	591	Q15334
NECAPVITAVTLSPS	FAT1	251	Q14517
SVDIVCTVDANPILP	NPHS1	756	O60500
ELVPTECQAVTAPVS	PASK	681	Q96RG2
PLEVPQSFCSSSIAV	MAGEB16	61	A2A368
TCQVEHPSVTSPLTV	HLA-DRB5	201	Q30154
VLVQCQPPAVVTSLA	LLGL2	581	Q6P1M3
TASQPCSIVDVEFLP	LPCAT4	256	Q643R3
VVPVAGSCVVDAVPA	EPHB4	216	P54760
VVSSEPVQVCSPVTA	MGA	1581	Q8IWI9
PVQVCSPVTAAVTTT	MGA	1586	Q8IWI9
SPPCITTVSVNESLL	KRT85	91	P78386
TPQQALDTPAVVTCF	LRRK1	1616	Q38SD2
LDTPAVVTCFLAVPV	LRRK1	1621	Q38SD2
TVPCCPTGLTVTQIT	FNDC7	541	Q5VTL7
VLTCDVSGVPAPTVT	HMCN2	3151	Q8NDA2
TGTTPVSAECPVVNE	MGAM	81	O43451
PCITTVSVNESLLTP	KRT86	76	O43790
QLQVIPVPISCSTTD	CWF19L1	416	Q69YN2
CTTIPSAPQAVISSV	EPHB2	321	P29323
NDCAPEVIVTSVSTP	PCDHGB2	341	Q9Y5G2
DELCIPFVVIPATVS	PFKM	516	P08237
PITCSETPTVSQLVS	POU6F1	116	Q14863
PLAAVTCTAPVNIAV	MVD	6	P53602
ENVSALPATVAVASP	MANSC1	221	Q9H8J5
ATAVVAPTSTVAVAP	MAZ	161	P56270
IAPGTCIPNAVEVSV	EPHB3	236	P54753
VTLEVLVAPAVPSCE	JAM2	126	P57087
VNVPRQPTVTSVCSE	PDLIM5	201	Q96HC4
LPSCTVTLELVVENP	PCDHGC3	101	Q9UN70
SVPCSDTVPVIAVSV	OSTM1	276	Q86WC4
VLPVCLATPEVNLTS	PRSS38	166	A1L453
TQPCPSLIDVVVVCD	ITGA2	166	P17301
CPEAIVCSPTAVNTQ	MTERF2	101	Q49AM1
GCPPLSSTAVISIQV	DCHS2	2641	Q6V1P9
CIVPENLPISSTICS	DCHS2	2776	Q6V1P9
FVIILATSQPCQTPD	GPRC6A	11	Q5T6X5
PVSTQACVIEPIVSI	KAT6A	1181	Q92794
FIDSPTVIAVPDLQC	FAM157B	361	P0CG42
CSLPVFLSISVVDQP	CDHR2	221	Q9BYE9
DVSTSIPSCIPFVAQ	IFTAP	131	Q86VG3
TVSTNPAVAVAEPVV	CABIN1	326	Q9Y6J0
LVIPTTIAFCSSINP	CTTNBP2	656	Q8WZ74
PPSVVVSCAGITQDE	HSD17B8	96	Q92506
SVGFVCESPTEQVLP	CDK5RAP3	211	Q96JB5
PEATVAATCAFPSVQ	LDHD	266	Q86WU2
TCQVEHPSVTSPLTV	HLA-DRB1	201	P01911
PSATVVVIKEASACP	MGARP	126	Q8TDB4
TTVPTCQAGPLTIQE	SELP	756	P16109
TLPVIVNIAAAPCDT	KNDC1	1206	Q76NI1
VATQTCQITPAEGPV	KNG1	121	P01042
NLSVTSLPEASVVCP	FHIP2A	241	Q5W0V3
SFGVQPCVSTVLVEP	FBXO30	586	Q8TB52
VTVAPFNPTVCDALL	S100PBP	146	Q96BU1
AVAVPPEATVAITTA	PPP6R2	891	O75170
PCITTVSVNESLLTP	KRT83	81	P78385
PSSEFQISVVDCQPV	NXT1	66	Q9UKK6
VVSVVTPGCNQLPTL	HEXA	96	P06865
TKAPVSVCVEPTASQ	TAF4B	46	Q92750
CVNVTEISDSVPSPV	SLC52A3	166	Q9NQ40
CLTTVPAENATVVPG	SLCO3A1	511	Q9UIG8
ESPITVEVNCTNPGT	TCAF1	526	Q9Y4C2
PVGSTASLCVSQVPA	PLEKHG4	651	Q58EX7
ITTIINCFINSSIPP	RGS22	1076	Q8NE09
VEQNSPAVCETISVP	RESF1	551	Q9HCM1
AVPIQSSVVLCSCPS	PDPK1	11	O15530
LPCTPVLVVATQTDQ	RHOH	106	Q15669
SETQPQVCAAVVLLP	SPATA31A7	1021	Q8IWB4
TPSCPVCQTAVTQAI	MEX3C	641	Q5U5Q3
VIPISCLTEFPNVVQ	RAP1GAP	141	P47736
PVLVSCDSAPCTVVQ	ITGA2B	906	P08514
SEVIIRVTCPLSSPQ	RIPK4	311	P57078
PEECRATVQPAQTLT	HHIP	591	Q96QV1
QQKVVSSPPCAAAVS	SKI	426	P12755
VSVPAPTNVLSLSVC	TGIF2	116	Q9GZN2
VQTKIEPVSPCSSVN	ATF6B	161	Q99941
APCVALTATATPQVQ	RECQL5	186	O94762
PEPVNLQASVTVSCD	PLA1A	436	Q53H76
SETQPQVCAAVVLLP	SPATA31A3	1021	Q5VYP0
TVSIDNPGAVQCPVT	FYTTD1	231	Q96QD9
LVQDQFPVTPVSTLC	VPS51	551	Q9UID3
TPVNCEQPDILVSST	TMF1	401	P82094
TVEQCTSQKIPEIPA	WASHC5	1106	Q12768
VATPAITVSNSCPAE	TFE3	311	P19532
SETQPQVCAAVVLLP	SPATA31A1	1021	Q5TZJ5
SETQPQVCAAVVLLP	SPATA31A5	1021	Q5VU36
DSCPTITVSPVITIQ	TRPV1	71	Q8NER1
QASFIPCPVDTSQVI	RYR3	846	Q15413
IAIVAETCSPFTVLP	SF3B1	1116	O75533
LVACTKVVAPTISSP	TLN1	716	Q9Y490
KVVAPTISSPVCQEQ	TLN1	721	Q9Y490
ICVTPTTCSNTIDLP	STAT3	711	P40763
ICTVAAAPVVPAVST	TNKS	96	O95271
NVSAEVCVPVTLVPV	ZBTB41	801	Q5SVQ8
TTVISPPVDVIASCV	NUP188	601	Q5SRE5
PPVDVIASCVNCLTV	NUP188	606	Q5SRE5
SGTCEAPVAVVTVTP	TBC1D10B	221	Q4KMP7
VFDVVVTDPSCPASV	TP53BP1	1916	Q12888
LPTIVAIADQNSVPC	ZEB1	811	P37275
PAIQSEPETVCNVAI	ZSWIM6	236	Q9HCJ5
SSTVQPVAAAATVVP	ZFR	231	Q96KR1
VSPTISSPVCQEQLI	TLN2	726	Q9Y4G6
QSVQELIPDSFVPCV	TRAPPC8	6	Q9Y2L5
CAALNVTVSPGPVVD	VSTM4	21	Q8IW00
HSVPTQLSTTVECVP	ZNF831	486	Q5JPB2
VECVPVTRSNSLPFV	ZNF831	496	Q5JPB2
KVPEVTCIPTTATLA	ZHX3	581	Q9H4I2
VAPAITTEATAQCIP	KIAA1958	376	Q8N8K9
PCITTVSVNESLLTP	KRT81	76	Q14533
VGTTPLVVTNPCTIA	NACA	436	E9PAV3
LVVTNPCTIAAAPTT	NACA	441	E9PAV3
PCTIAAAPTTTFEVA	NACA	446	E9PAV3
TIPVAPTVVNAAAST	PPP1R12A	631	O14974